Distribution of Clostridium difficile strains from a North American, European and Australian trial of treatment for C. difficile infections: 2005-2007

Anaerobe

Volumn 15, Issue 6, 2009, Pages 230-233

  Cheknis, Adam K ^a   Sambol, Susan P ^b   Davidson, David M ^c   Nagaro, Kristin J ^a   Mancini, Maria C ^c   Aida Hidalgo Arroyo, G ^d   Brazier, Jon S ^d   Johnson, Stuart ^a,b   Gerding, Dale N ^a,b  

^a HINES VA HOSPITAL   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^c GENZYME CORPORATION   (United States)

^d UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Bacterial strains; Clostridium difficile

Indexed keywords

METRONIDAZOLE; TOLEVAMER; VANCOMYCIN;

ARTICLE; AUSTRALIA; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; EUROPE; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; NORTH AMERICA; PRIORITY JOURNAL; RIBOTYPING; SPECIES DISTRIBUTION;

AUSTRALIA; BACTERIAL TYPING TECHNIQUES; CLOSTRIDIUM DIFFICILE; DNA RESTRICTION ENZYMES; ENTEROCOLITIS, PSEUDOMEMBRANOUS; EUROPE; HUMANS; NORTH AMERICA; POLYMERASE CHAIN REACTION; RIBOTYPING;

BACTERIA (MICROORGANISMS); CLOSTRIDIUM DIFFICILE;

EID: 70649111291     PISSN: 10759964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2009.09.001     Document Type: Article

References (17)

1. McDonald L.C., Owings M., and Jernigan D.B. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis 12 (2006) 409-415
2. Bouza E, Dryden M, Mohammed R, Peppe J, Chasan-Taber S, Donovan J, et al. Results of a phase III trial comparing tolevamer, vancomycin and metronidazole in patients with Clostridium difficile-associated diarrhoea. In: The18th European congress of clinical microbiology and infectious diseases. Barcelona, Spain; 2008.
3. Louie T, Gerson M, Grimard D, Johnson S, Poirier A, Weiss K, et-al. Results of a phase III trial comparing tolevamer, vancomycin and metronidazole in patients with Clostridium difficile-associated diarrhea (CDAD). In: The 47th annual interscience conference on antimicrobial agents and chemotherapy. Chicago, IL; 2007.
4. McDonald L.C., Killgore G.E., Thompson A., Owens Jr. R.C., Kazakova S.V., Sambol S.P., et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 353 (2005) 2433-2441
5. Loo V.G., Poirier L., Miller M.A., Oughton M., Libman M.D., Michaud S., et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 353 (2005) 2442-2449
6. Jhung M.A., Thompson A.D., Killgore G.E., Zukowski W.E., Songer G., Warny M., et al. Toxinotype V Clostridium difficile in humans and food animals. Emerg Infect Dis 14 (2008) 1039-1045
7. Johnson S., Sambol S.P., Brazier J.S., Delmee M., Avesani V., Merrigan M.M., et al. International typing study of toxin A-negative, toxin B-positive Clostridium difficile variants. J Clin Microbiol 41 (2003) 1543-1547
8. Johnson S., Samore M.H., Farrow K.A., Killgore G.E., Tenover F.C., Lyras D., et al. Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals. N Engl J Med 341 (1999) 1645-1651
9. Belmares J, Johnson S, Parada JP, Olson MM, Clabots CR, Bettin KM, et al. Molecular epidemiology of Clostridium difficile over 10 years (1982-1991) in one tertiary care hospital. In: The 19th annual scientific meeting of the society for healthcare epidemiology of America. San Diego, CA; 2009.
10. Mekonen E.T., Gerding D.N., Sambol S.P., Pottinger J.M., Pulvirenti J.J., Marsh D., et al. Predominance of a single restriction endonuclease analysis group with intrahospital subgroup diversity among Clostridium difficile isolates at two Chicago hospitals. Infect Control Hosp Epidemiol 23 (2002) 648-652
11. Stubbs S.L., Brazier J.S., O'Neill G.L., and Duerden B.I. PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol 37 (1999) 461-463
12. Wilson K.H., Kennedy M.J., and Fekety F.R. Use of sodium taurocholate to enhance spore recovery on a medium selective for Clostridium difficile. J Clin Microbiol 15 (1982) 443-446
13. Clabots C.R., Gerding S.J., Olson M.M., Peterson L.R., and Gerding D.N. Detection of asymptomatic Clostridium difficile carriage by an alcohol shock procedure. J Clin Microbiol 27 (1989) 2386-2387
14. Clabots C.R., Johnson S., Bettin K.M., Mathie P.A., Mulligan M.E., Schaberg D.R., et al. Development of a rapid and efficient restriction endonuclease analysis typing system for Clostridium difficile and correlation with other typing systems. J Clin Microbiol 31 (1993) 1870-1875
15. Killgore G., Thompson A., Johnson S., Brazier J., Kuijper E., Pepin J., et al. Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-repeat analysis, amplified fragment length polymorphism, and surface layer protein A gene sequence typing. J Clin Microbiol 46 (2008) 431-437
16. Brazier J.S., and Borriello S.P. Microbiology, epidemiology and diagnosis of Clostridium difficile infection. Curr Top Microbiol Immunol 250 (2000) 1-33
17. Goorhuis A., Bakker D., Corver J., Debast S.B., Harmanus C., Notermans D.W., et al. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis 47 (2008) 1162-1170